Drug General Information |
Drug ID |
D0B9DR
|
Former ID |
DNC003891
|
Drug Name |
1-Benzyl-4-(2-iodo-pyrrol-1-yl)-piperidine
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C16H19IN2
|
Canonical SMILES |
C1CN(CCC1N2C=CC=C2I)CC3=CC=CC=C3
|
InChI |
1S/C16H19IN2/c17-16-7-4-10-19(16)15-8-11-18(12-9-15)13-14-5-2-1-3-6-14/h1-7,10,15H,8-9,11-13H2
|
InChIKey |
LZMIVAWAFVXKJL-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Dopamine D1 receptor |
Target Info |
Inhibitor |
[1]
|
D(4) dopamine receptor |
Target Info |
Inhibitor |
[1]
|
D(2) dopamine receptor |
Target Info |
Inhibitor |
[1]
|
D(3) dopamine receptor |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
Calcium signaling pathway
|
cAMP signaling pathway
|
Neuroactive ligand-receptor interaction
|
Gap junction
|
Dopaminergic synapse
|
Parkinson's disease
|
Cocaine addiction
|
Amphetamine addiction
|
Morphine addiction
|
Alcoholismhsa04080:Neuroactive ligand-receptor interaction
|
Dopaminergic synapsehsa04015:Rap1 signaling pathway
|
PANTHER Pathway
|
Dopamine receptor mediated signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
|
Dopamine receptor mediated signaling pathway
|
Nicotine pharmacodynamics pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
Nicotine pharmacodynamics pathway
|
PathWhiz Pathway
|
Dopamine Activation of Neurological Reward System
|
Reactome
|
Dopamine receptors
|
G alpha (s) signalling eventsR-HSA-390651:Dopamine receptors
|
G alpha (i) signalling eventsR-HSA-390651:Dopamine receptors
|
G alpha (i) signalling events
|
WikiPathways
|
Hypothetical Network for Drug Addiction
|
Monoamine GPCRs
|
GPCRs, Class A Rhodopsin-like
|
Genes and (Common) Pathways Underlying Drug Addiction
|
GPCR ligand binding
|
GPCR downstream signalingWP666:Hypothetical Network for Drug Addiction
|
GPCR downstream signaling
|
Nicotine Activity on Dopaminergic Neurons
|
GPCRs, OtherWP666:Hypothetical Network for Drug Addiction
|
Nicotine Activity on Dopaminergic NeuronsWP58:Monoamine GPCRs
|
GPCRs, Other
|
References |
REF 1 | Bioorg Med Chem Lett. 1999 Nov 1;9(21):3143-6.Piperidinylpyrroles: design, synthesis and binding properties of novel and selective dopamine D4 receptor ligands. |